Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma

Keyphrases

• Therapeutic Target 100%
• Uterine Serous 100%
• Molecular Sequencing 100%
• Serous Adenocarcinoma 100%
• Endometrial Cancer 66%
• Molecular Genetics 33%
• Tumor 33%
• Disease Progression 33%
• Older Women 33%
• Fluorescence in Situ Hybridization 33%
• Overexpression 33%
• Immunohistochemistry 33%
• Molecular Diagnostics 33%
• Complete Response 33%
• Chemotherapy Regimen 33%
• Trastuzumab 33%
• Her2neu 33%
• Genome Sequencing 33%
• ErbB2 33%
• Focal Amplification 33%

Medicine and Dentistry

• Adenocarcinoma 100%
• Endometrial Cancer 66%
• Disease 33%
• Neoplasm 33%
• Recurrent Disease 33%
• Fluorescence in Situ Hybridization 33%
• Immunohistochemistry 33%
• Chemotherapy Regimens 33%
• Trastuzumab 33%